AbbVie Inc. (ABBV) Social Stream



AbbVie Inc. (ABBV): $107.91

1.02 (+0.95%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About ABBV

$ATNF 👉🏻 The founders have significant expertise in developing new therapeutics that were sold to big pharma for billions. They are renowned for development of some of the largest-selling drugs to ever come to market. Now they aim to do it again with a pipeline of drug candidates in sequential stages of development that address large untapped markets. The founding scientists at 180 Life Sciences discovered the anti-TNF drug class that led to Remicade, the fourth all-time best-selling drug in the world. Presently owned by $JNJ , Remicade has exceeded $90 billion in total sales since approval. $ABBV licensed the anti-TNF patents from these scientists for use with Humira, the second best-selling drug in the world, with lifetime sales of $137 billion. $AMGN licensed the seventh best seller, Enbrel, that treats psoriasis and rheumatoid arthritis and has generated over $81 billion lifetime sales. $NVS licensed the world’s 12th best-selling drug, Diovan, has over $60 billion in sales.
MDInvestments, published April 13, 2021

What Else are ABBV Traders Talking About?


Other tickers frequently mentioned alongside ABBV are ATNF, JNJ, AMGN and NVS.

Other Notable StockTweets About ABBV


Seeing as pretty much all the local banks in my area no longer permit me inside their premises, I just spent all afternoon at the park looking for distracted mothers so I could swipe lollipops from their kids. And seeing how my some of my longshot tickers have done today, it looks like my dinner today will be entitled ''How many licks does it take to get to the center of a Tootsie Pop?''

$LKNCY The results of my prediction for this one today is drawing more flies than an open bag of fertilizer. However, my faith remains unshaken.

$ATNF HUGE shoutout to @Mnhotrodbuilder for this pick. Thanks to you, it's fresh muffins fer me in the morning!!!

$ADMA 6 new insults I wrote last nite for this one, & today they go green just to spite me. Yes, of course I'm ok with that.

$ABBV If you were a blow up doll of mine you'd have a lotta patches.

$RICE Yeah. Of course. This is up 50%, but my Luckin & Best ain't doin me diddly squat.

: )

jbh973, published April 8, 2021

$ATNF 👉🏻 The founders have significant expertise in developing new therapeutics that were sold to big pharma for billions. They are renowned for development of some of the largest-selling drugs to ever come to market. Now they aim to do it again with a pipeline of drug candidates in sequential stages of development that address large untapped markets. The founding scientists at 180 Life Sciences discovered the anti-TNF drug class that led to Remicade, the fourth all-time best-selling drug in the world. Presently owned by $JNJ , Remicade has exceeded $90 billion in total sales since approval. $ABBV licensed the anti-TNF patents from these scientists for use with Humira, the second best-selling drug in the world, with lifetime sales of $137 billion. $AMGN owns the seventh best seller, Enbrel, that treats psoriasis and rheumatoid arthritis and has generated over $81 billion lifetime sales. $NVS owns the world’s 12th best-selling drug, Diovan, has over $60 billion in sales.

MDInvestments, published April 3, 2021

$ATNF ATNF may only be 5 months public (& $150M market cap).. but this team has one of best track records in the biotech world.... which can rival any Large Cap Bio ( $ABBV licensed their patents for Use in Humira, the current #1 best selling drug).
The ATNF team is responsible for (among many other things) discovering, completing the first successful trial & approval (Remicade- the 4th all time best selling drug in the world- with over $90B total sales).. of the top selling class of drugs on the market... and by far.
The Anti-TNF drugs were 40% of top 10 US drugs Sales in 2020 (#1, #3, #10 on the list below).
Now they have formed ATNF to gain approval for anti-TNF treatment of Fibrosis conditions with Unmet needs & to gain approval of the next top selling class of drug to replace the current anti-TNF Biologics, to treat arthritic & autoimmune diseases, and with much fewer side effects and risk factors (a class projected to be $150B by 2025).

SCNC, published March 29, 2021

$ATNF ATNF may be 4 months public (& just over $100M market cap).. but this team has one of best track records in the biotech world.... which can rival any Large Cap Bio ( $ABBV licensed their patents for Use in Humira, the current #1 best selling drug).
The ATNF team is responsible for (among many other things) discovering, completing the first successful trial & approval (Remicade- the 4th all time best selling drug in the world- with over $90B total sales).. for the top selling class of drugs on the market... and by far.
The Anti-TNF drugs were 40% of top 10 US drugs Sales in 2020 (#1, #3, #10 on the list below).
Now they have formed ATNF to gain approval for anti-TNF treatment of Fibrosis conditions with Unmet needs & to gain approval of the next top selling class of drug to replace the current anti-TNF Biologics, to treat arthritic & autoimmune diseases, and with much fewer side effects and risk factors (a class projected to be $150B by 2025.
$GILD $ABBV $JNJ $AMGN

SCNC, published March 16, 2021

Loading social stream, please wait...



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6093 seconds.